- Brand names:
- Pharmaceutical Company:
- Condition/Indication:
- Meeting Date: November 2010
- Public Summary Document (PSD) November 2010 PBAC Meeting - PDF
Plerixafor – November 2010
Plerixafor, solution for subcutaneous injection, 20 mg per mL, 1.2 mL, Mozobil®
Last updated
17 March 2011